DarrenRossGitelmanMDFAAN, FANA

Neurodegenerative, Dementia & Geriatrics

Senior Medical Director, Advocate Memory Center, Professor of Medicine - Rosalind Franklin University of Medicine and Science, Adjunct Lecturer, Feinberg School of Medicine, Northwestern University

Join to view full profile

Dr. Gitelman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gitelman's full profile

Already have an account?

Office
1875 Dempster St.
Suite 520
Park Ridge, IL 60068
Phone+1 847-720-6464

Fax+1 847-720-6463

Education & Training

Beth Israel Deaconess Medical Center1992 - 1994
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1989 - 1992
NewYork-Presbyterian/Columbia University Irving Medical CenterPost-Doctoral Fellowship, 1988 - 1989
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1986 - 1988
New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1985 - 1986
Washington University in St. Louis School of MedicineClass of 1985

Certifications & Licensure

IL State Medical License 1994 - 2026
WI State Medical License 2024 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Psychiatry and Neurology Neurology
United Council for Neurologic SubspecialtiesBehavioral Neurology & Neuropsychiatry

Awards, Honors, & Recognition

Top Doctor Chicago Magazine, 2020-2024
Top Doctor Castle Connolly, 2015-2024
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease Start of enrollment: 2008 Dec 19
Completed
Phase 3
PharmacoMRI of Parkinson Disease Start of enrollment: 2011 Jun 01
Completed
Not Applicable
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 Start of enrollment: 2012 Dec 01
Recruiting
Phase 2, Phase 3
Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Start of enrollment: 2013 Oct 01
Terminated
Phase 3
221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease Start of enrollment: 2015 Aug 13
Terminated
Phase 3
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study Start of enrollment: 2015 Sep 01
Completed
Phase 2
A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's Disease Start of enrollment: 2017 Jan 26
Completed
Phase 2
U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk Start of enrollment: 2019 Jan 08
Active, not recruiting
Not Applicable
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease Start of enrollment: 2019 Mar 27
Active, not recruiting
Phase 3
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 Start of enrollment: 2020 Mar 02
Active, not recruiting
Phase 3
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease Start of enrollment: 2021 Nov 18
Active, not recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) Start of enrollment: 2020 Jun 19
Active, not recruiting
Phase 3
Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey Start of enrollment: 2023 Nov 15
Recruiting
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

The POINTER Imaging baseline cohort: Associations between multimodal neuroimaging biomarkers, cardiovascular health, and cognition.
Theresa M Harrison, Tyler Ward, Jacinda Taggett, Pauline Maillard, Samuel N Lockhart
Alzheimer's & Dementia. 2024-12-06
10 citations
Study design and methods: U.S. study to protect brain health through lifestyle intervention to reduce risk (U.S. POINTER).
Laura D Baker, Heather M Snyder, Mark A Espeland, Rachel A Whitmer, Miia Kivipelto
Alzheimer's & Dementia. 2024-02-01
Developing Topics.
Laura D Baker, Heather M Snyder, Mark A Espeland, Rachel A Whitmer, Miia Kivipelto
Alzheimer's & Dementia. 2023-12-01

Journal Articles

Cognitive impairment in aging physicians
G Devi, DR Gitelman, D Press, K Daffner, Neurology: Clinical Practice, 3/13/2020

Press Mentions

4 Alzheimer’s Disease Questions AnsweredOctober 10th, 2024
‘The Hemsworth Alzheimer’s Disease Gene’: Revisiting the Nature-Nurture DebateJanuary 17th, 2023
An Alzheimer’s Treatment Receives Accelerated ApprovalJanuary 12th, 2023
Join now to see all

Grant Support

Education, digital tools, and diagnostic support to increase PCP-based cognitive testing in patients 65 years and olderDavos Alzheimer's Collaborative2022–2023
The Parkinson’s Progression Markers Initiative (PPMI) – T1 Standardization Sub-StudyMichael J Fox Foundation2014–2016
The Parkinson’s Progression Markers Initiative (PPMI) – rsMRI Sub-StudyMichael J Fox Foundation2012–2016
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Effectiveness of Immune Globulin Intravenous (Human), 10% Solution (IGIV, 10%) for the Treatment of Mild to Moderate Alzheimer's Disease (ADBaxter Healthcare Corporation2012–2013
PharmacoMRI of Parkinson’s disease: A Pilot Study of Drug Effects on ConnectivityPaul Ruby Foundation2011–2012
High Resolution Diffusion tensor MRI Imaging as a Biomarker of Parkinson’s Disease Diagnosis and Disease ProgressionMichael J Fox Foundation2009–2012
Structural And Functional Mapping Of Progressive AphasiaNational Center For Research Resources2004–2009
Neural Network Stability And Variability In Normal AgingNational Institute On Aging1999–2003

Committees

Chair, United Council for Neurologic Subspecialties Certification Council 2020 - 2023

Professional Memberships

American Neurological Association
Fellow
International Society to Advance Alzheimer's Research and Treatment
Member
American Academy of Neurology - AAN
Fellow
International Society for Frontotemporal Dementia
Member

External Links

Advocate Memory Centerhttp://www.advocatehealth.com/memorycenter
AMG Doctorshttp://doctors.advocatehealth.com/a/darren-r-gitelman-park-ridge-neurology
Northwestern Universityhttp://www.neurology.northwestern.edu/faculty/profile.html?xid=14246